Dan Camardo, Athersys CEO
Athersys’ woes continue as Aspire Capital axes its relationship with the biotech
While Athersys has been in the penny stock twilight zone since 2021, the company has hit several major speed bumps in the past few months …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
